title: Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: role of oxidative stress pathway genes.
authors.forename: B K
authors.initials: BK
authors.lastname: Thelma
authors.forename: Arun K
authors.initials: AK
authors.lastname: Tiwari
authors.forename: Smita N
authors.initials: SN
authors.lastname: Deshpande
authors.forename: Bernard
authors.initials: B
authors.lastname: Lerer
authors.forename: Vishwajit L
authors.initials: VL
authors.lastname: Nimgaonkar
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology* / Q000209:etiology*; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D009434:Neural Pathways / Q000503:physiopathology*; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000235:genetics*; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics
chemical_list: D014150:Antipsychotic Agents